Cytogam (CSL Behring AG)


Welcome to the PulseAid listing for the Cytogam drug offered from CSL Behring AG. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.

LABELER NAME / MANUFACTURER: CSL Behring AG
NON-PROPRIETARY NAME: Human Cytomegalovirus Immune Globulin
SUBSTANCE NAME: HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2009-01-06
END MARKETING DATE: 0000-00-00


Cytogam PLASMA DERIVATIVE Details:

Item DescriptionCytogam from CSL Behring AG
LABELER NAME: CSL Behring AG
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 2009-01-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44206-532_956999c6-95ee-4889-b149-4ab73f43f931
PRODUCT NDC: 44206-532
APPLICATION NUMBER: BLA103189

Other HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
CSL Behring AGCytogam